Market Tracker

12/19 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

During the Trading Day
40.11 +2.90 / +7.79%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
39.99 -0.12 / -0.30%
 
Volume: 191.4K

Today’s Trading

Previous close37.21
Today’s open37.23
Day’s range36.06 - 40.29
Volume1,075,555
Average volume (3 months)1,134,051
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-33.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book16.95

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.13-0.32%
LGNDLigand Pharmaceutica...+0.19+0.36%
EBSEmergent BioSolution...+0.07+0.26%
MACKMerrimack Pharmaceut...+0.62+5.95%
Data as of 4:05pm ET, 12/19/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts